InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
4
已披露卖出
2
T+90 胜率
100%
T+90 平均收益
+23.8%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Ryan Barbara, Director. Director active across 5 companies, notably Indivior Pharmaceuticals, Inc.. In total, 23 disclosures have been recorded. Split: 4 buys · 2 sells. Total volume traded: €39k. Activity tracked since 15 January 2022. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ryan Barbara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
6,518 股0Common StockSEC:0001827169-26-000013:0
8 股@ US$31.08519.8% 占其流量Common StockSEC:0001827169-26-000010:0
标准退出：2026年6月11日 (T+90)
31 股@ US$32.5680.2% 占其流量Common StockSEC:0001827169-26-000008:0
标准退出：2026年6月7日 (T+90)
200 股@ US$10.17250.7% 占其流量Common StockSEC:0001193125-26-102581:0
400 股@ US$10.85831.5% 占其流量Common StockSEC:0001193125-26-091707:0
3,722 股0Common StockSEC:0001827169-26-000006:0
775 股@ US$35.3926100.0% 占其流量Ordinary SharesSEC:0001827169-26-000004:0
标准退出：2026年4月5日 (T+90)
1,601 股@ US$11.096.2% 占其流量Common StockSEC:0001193125-25-306678:0
1,281 股@ US$13.866.6% 占其流量Common StockSEC:0001193125-25-195090:0
2,476 股@ US$7.177.2% 占其流量Common StockSEC:0000950170-25-081608:0
2,019 股@ US$8.798.5% 占其流量Common StockSEC:0000950170-25-033523:0
24,229 股@ US$0.738.3% 占其流量Common StockSEC:0000950170-24-132525:0
21,649 股@ US$0.828.0% 占其流量Common StockSEC:0000950170-24-103750:0
17,841 股@ US$0.998.1% 占其流量Common StockSEC:0000950170-24-069215:0
18,685 股@ US$0.958.2% 占其流量Common StockSEC:0000950170-24-026422:0
17,068 股@ US$1.048.1% 占其流量Common StockSEC:0000950170-23-068322:0
12,158 股@ US$1.468.1% 占其流量Common StockSEC:0000950170-23-046774:0
10,086 股@ US$1.768.2% 占其流量Common StockSEC:0000899243-23-014414:0
8,493 股@ US$2.098.3% 占其流量Common StockSEC:0000899243-23-006913:0
6,801 股@ US$2.618.5% 占其流量Common StockSEC:0000899243-22-037650:0
13,550 股@ US$2.6217.7% 占其流量Common StockSEC:0000899243-22-031529:0
10,526 股@ US$0.95100.0% 占其流量Common StockSEC:0001493152-22-015911:0
标准退出：2022年8月30日 (T+90)
8,588 股0Common StockSEC:0001493152-22-001529:0
23 条申报中的 23 条
About Ryan Barbara
Ryan Barbara is a director at MiNK Therapeutics, Inc., Indivior Pharmaceuticals, Inc., INVO Bioscience, Inc. and Indivior PLC. The file shows 23 filings in total, and across the sampled recent filings from 2022-01-18 to 2026-05-14, the buy amount is EUR 33912 and the sell amount is EUR 5445, with the modal transaction nature listed as Attribution.
